· Gurgaon, Haryana
Novo Nordisk India Private Limited operates its Indian corporate headquarters from Gurgaon (Gurugram), Haryana. As the India subsidiary of the global Danish pharmaceutical giant, Novo Nordisk India focuses on serious chronic diseases including diabetes, obesity, haemophilia, and growth disorders. The company is a market leader in insulin and diabetes care products in India.
Novo Nordisk India’s portfolio includes modern insulins (Tresiba, Victoza, Ryzodeg, NovoRapid, Insulatard, Mixtard), GLP-1 receptor agonists, human growth hormone (Norditropin), and coagulation factor products for haemophilia. The company invests significantly in patient education and diabetes awareness programmes across India.
Novo Nordisk holds a leading position in insulin sales in India and is committed to making insulin accessible through various affordability and access programmes. The Gurgaon office drives commercial strategy, regulatory affairs, medical affairs, and market access for the Indian market.
Company: Novo Nordisk India Pvt. Ltd.
Location: Gurgaon (Gurugram), Haryana
Business Type: Global Pharmaceutical Subsidiary – Diabetes & Chronic Disease
No products found.
TeraMeraBazar.com
Powered by Bhuvion Labs Private Limited
A dedicated business networking and lead-generation platform for the pharmaceutical industry. We connect pharmaceutical companies, manufacturers, PCD franchise providers, marketers, distributors and other industry professionals — helping them promote their offerings and find genuine business opportunities.